Ottobock, DE000BCK2223

Goldman cut Ottobock target to EUR 75: Ottobock stock gains 1.32 percent

Published on 10/26/2026 at 10:32 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
North America weakness hit the outlook on October 21, 2026. Ottobock stock costs EUR 49.95 on October 26, 2026 versus EUR 49.30 Xetra close.

Analyst caution and operating growth

  • Goldman Sachs cut its target to EUR 75.00 on October 21, 2026.
  • Core revenue rose 11.70 percent to EUR 180.0 million in fiscal year 2025.
  • Ottobock stock trades at EUR 49.95 at 10:30 a.m. CET at Lang & Schwarz on October 26, 2026, 1.32 percent above the Xetra close of October 23, 2026.
  • Ottobock is scheduled to publish its third-quarter 2026 report on November 12, 2026.
Ottobock, DE000BCK2223, Illustration mit AI erstellt.

Ottobock stock (ISIN DE000BCK2223) was trading at EUR 49.95 at Lang & Schwarz on October 26, 2026 at 10:30 a.m. CET, up 1.32 percent from the Xetra close of October 23, 2026 at EUR 49.30. On October 21, 2026, MarketScreener reported that Goldman Sachs had cut its price target from EUR 88.00 to EUR 75.00 while retaining a Buy rating.

Goldman flags North America weakness

Analyst Richard Felton said continued weakness in North America could weigh on Ottobock's third-quarter revenue growth. The target reduction also included roughly 2 percent cuts to Goldman Sachs forecasts for adjusted operating earnings and adjusted earnings per share for the current year, 2027 and 2028.

The warning contrasts with a more constructive view from Deutsche Bank Research. In an October 20, 2026 note, Boerse.de reported that the bank kept its Buy rating and EUR 85.00 target, while expecting 6.00 percent organic revenue growth in the next quarterly figures.

Growth remains the counterweight

Ottobock's fiscal year 2025 core revenue reached EUR 180.0 million, up 11.70 percent year over year, according to the company's investor-relations page. Adjusted core EBITDA increased 29.50 percent to EUR 46.76 million, while adjusted EBITDA margin rose to 2.93 percent from 2.57 percent. These figures provide a stronger operating base than the short-term North America concern.

What dates matter next?

The next scheduled company event is the third-quarter 2026 report on November 12, 2026. Ottobock's investor-relations calendar also lists a BNP Paribas MidCap CEO Conference on November 16, 2026. The chronology is clear: the company reported 11.70 percent core-revenue growth for fiscal year 2025 on August 13, 2026, Deutsche Bank maintained an EUR 85.00 target on October 20, 2026, and Goldman Sachs cut its target to EUR 75.00 on October 21, 2026.

Stock balances risk and valuation

For investors, the key tension is the gap between near-term execution risk and the company's recent operating improvement. The Goldman target remains EUR 25.05 above the current Lang & Schwarz price, while Deutsche Bank's target is EUR 35.10 above it. Ottobock develops products in prosthetics, neuro-orthotics and exoskeletons and operates in medical equipment, supplies and distribution.

The further course of trading is shown by the continuously updated real-time quote of Ottobock stock.

Ottobock stock key facts

  • Company: Ottobock SE & Co. KGaA
  • ISIN: DE000BCK2223
  • WKN: BCK222
  • Ticker: OBCK
  • Primary exchange: Xetra
  • Price Lang & Schwarz (as of October 26, 2026, 10:30 a.m. CET): EUR 49.95
  • Change versus Xetra close: plus 1.32 percent
  • Xetra close (October 23, 2026): EUR 49.30
  • Sector / Industry: Medical Equipment, Supplies & Distribution

Market context: Market report DAX.

More news and analyses on Ottobock stock

Disclaimer...
en | DE000BCK2223 | OTTOBOCK | boerse | 70413599 | bgmi